Humana Readies New Online Assessment Tool


Turning to the Internet to help identify its high-risk members and monitor their care, Humana has embraced a Rhode Island company's new personal-health assessment tool. Offered by QualityMetric Inc., the online service (www. amIhealthy.com) allows anyone with a personal computer to create a unique health profile that tells what the results mean, and what a person should do about them.

The system uses a dynamic assessment, meaning that as a user answers questions, irrelevant questions are skipped until a reliable profile can be generated. Patients are encouraged to print their profiles and take them to their physicians, who in turn, can help patients work toward improvement goals and learn to monitor their own progress. The program, which can be completed in as few as five questions, was developed by John Ware, Ph.D., QualityMetric's president and developer of the SF-36 and SF-12 surveys.

While the logistics of how it will capture and use personal health-assessment data are yet to be worked out, Humana envisions being able to detect illnesses and intervene early in the disease process.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.